(Q33538444)

27 July 2017

1 reference

title

Clinical significance of angiogenic factors in breast cancer (English)

1 reference

27 July 2017

1 reference

Locopo N

1

1 reference

27 July 2017

Fanelli M

series ordinal

2

1 reference

27 July 2017

Gasparini G

series ordinal

3

1 reference

27 July 2017

language of work or name

English

0 references

publication date

1 January 1998

1 reference

Breast Cancer Research and Treatment

27 July 2017

1 reference

27 July 2017

52

1 reference

27 July 2017

159-173

1 reference

27 July 2017

1-3

1 reference

https://scigraph.springernature.com/pub.10.1023/a:1006175504673

27 July 2017

0 references

cites work

What Is the Evidence That Tumors Are Angiogenesis Dependent?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Angiogenesis in cancer, vascular, rheumatoid and other disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Mechanisms of angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Isolation of putative progenitor endothelial cells for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Endothelial cell activation. A central pathophysiological process

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Suppression of p53 activity and p21WAF1/CIP1 expression by vascular cell integrin alphaVbeta3 during angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Oncogenes as inducers of tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Requirement of vascular integrin alpha v beta 3 for angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The role of alpha v-integrins in tumour progression and metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Endothelial apoptosis in Braf-deficient mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Endostatin: an endogenous inhibitor of angiogenesis and tumor growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Natural killer cells, adhesion and tumor angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Adhesion of tumour-infiltrating lymphocytes to endothelium: a phenotypic and functional analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Biological properties of VEGF/VPF receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

What is the role of vascular endothelial growth factor-related molecules in tumor angiogenesis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Vascular endothelial growth factors VEGF-B and VEGF-C are expressed in human tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Platelet-derived endothelial cell growth factor thymidine phosphorylase in tumour growth and response to therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The activities of thymidine metabolising enzymes during the cell cycle of a human lymphocyte cell line LAZ-007 synchronised by centrifugal elutriation

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The angiogenic factor platelet-derived endothelial cell growth factor/thymidine phosphorylase is up-regulated in breast cancer epithelium and endothelium

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Positive immunostaining for platelet derived growth factor (PDGF) is an adverse prognostic factor in patients with advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Association of tumour necrosis factor alpha and its receptors with thymidine phosphorylase expression in invasive breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The ins and outs of fibroblast growth factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The role of angiogenic growth factors in breast cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

MCF-7 breast carcinoma cells overexpressing FGF-1 form vascularized, metastatic tumors in ovariectomized or tamoxifen-treated nude mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Low levels of basic fibroblast growth factor (bFGF) are associated with a poor prognosis in human breast carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Fibroblast growth factor 2 in breast cancer: occurrence and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Elevated levels of the angiogenic cytokines basic fibroblast growth factor and vascular endothelial growth factor in sera of cancer patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The location of acidic fibroblast growth factor in the breast is dependent on the activity of proteases present in breast cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Differential expression of vascular endothelial growth factor mRNA vs protein isoform expression in human breast cancer and relationship to eIF-4E.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Association of vascular endothelial growth factor expression with tumor angiogenesis and with early relapse in primary breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Clinical significance of the determination of angiogenic factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Inhibition of vascular endothelial growth factor-induced angiogenesis suppresses tumour growth in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Time-dependent vascular regression and permeability changes in established human tumor xenografts induced by an anti-vascular endothelial growth factor/vascular permeability factor antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Antiangiogenic drugs as a novel anticancer therapeutic strategy. Which are the more promising agents? What are the clinical developments and indications?

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The modulation of thrombospondin and other naturally occurring inhibitors of angiogenesis during tumor progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Suppression of tumor-forming ability and related traits in MCF-7 human breast cancer cells by fusion with immortal mammary epithelial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Gene therapy with p53 and a fragment of thrombospondin I inhibits human breast cancer in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Angiostatin gene transfer: inhibition of tumor growth in vivo by blockage of endothelial cell proliferation associated with a mitosis arrest

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The endogenous oestrogen metabolite 2-methoxyoestradiol inhibits angiogenesis and suppresses tumour growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Cell adhesion and angiogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Integrins and vascular extracellular matrix assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Detection of tumor angiogenesis in vivo by alphaVbeta3-targeted magnetic resonance imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Comparative analysis of the expression of the extracellular matrix protein tenascin in normal human fetal, adult and tumor tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The influence of angiogenesis research on management of patients with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Quantitative angiogenesis assays: progress and problems

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

The rationale and future potential of angiogenesis inhibitors in neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Relationship of elevated tumour thymidine phosphorylase in node-positive breast carcinomas to the effects of adjuvant CMF

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Quantitation and prognostic value of breast cancer angiogenesis: Comparison of microvessel density, Chalkley count, and computer image analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

Cellular changes on the route to metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Induction of endothelial cell apoptosis by TNF alpha: modulation by inhibitors of protein synthesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Angiostatin induces and sustains dormancy of human primary tumors in mice

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

During angiogenesis, vascular endothelial growth factor and basic fibroblast growth factor regulate natural killer cell adhesion to tumor endothelium

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Vascular permeability factor (vascular endothelial growth factor) expression and angiogenesis in patients with ductal carcinoma in situ of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Vascular endothelial growth factor and platelet-derived growth factor are potential angiogenic and metastatic factors in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Vascular endothelial growth factor (VEGF) in human breast cancer: Correlation with disease-free survival

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Co-determination of the angiogenic factors thymidine phosphorylase and vascular endothelial growth factor in node-negative breast cancer: prognostic implications

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

What is the role of thymidine phosphorylase in tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Up-regulation of thymidine phosphorylase expression is associated with a discrete pattern of angiogenesis in ductal carcinomasin situ of the breast

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Thrombospondin and transforming growth factor-beta 1 increase expression of urokinase-type plasminogen activator and plasminogen activator inhibitor-1 in human MDA-MB-231 breast cancer cells

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

In situ detection of tissue factor in vascular endothelial cells: correlation with the malignant phenotype of human breast disease

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

67-kDa laminin-receptor expression adds prognostic information to intra-tumoral microvessel density in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Clinical studies with angiogenesis inhibitors: biological rationale and challenges for their evaluation

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1006175504673

7 January 2021

Identifiers

DOI

10.1023/A:1006175504673

1 reference

Dimensions Publication ID

27 July 2017

0 references

1 reference